The microbiota and the gut–liver axis in primary sclerosing cholangitis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-09
DOI
10.1038/s41575-022-00690-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens
- (2022) Laura Valestrand et al. AMERICAN JOURNAL OF PATHOLOGY
- Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort
- (2022) Youwen Qin et al. NATURE GENETICS
- Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project
- (2022) Esteban A. Lopera-Maya et al. NATURE GENETICS
- Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
- (2022) Claudia D. Fuchs et al. Nature Reviews Gastroenterology & Hepatology
- A Parallel Tracking of Salivary and Gut Microbiota Profiles Can Reveal Maturation and Interplay of Early Life Microbial Communities in Healthy Infants
- (2022) Sofia Reddel et al. Microorganisms
- Small Intestinal Bacterial Overgrowth Pathophysiology and its Implications for Definition and Management
- (2022) Daniel Bushyhead et al. GASTROENTEROLOGY
- Dietary management of adults with IBD — the emerging role of dietary therapy
- (2022) Jessica A. Fitzpatrick et al. Nature Reviews Gastroenterology & Hepatology
- MAIT cells in liver inflammation and fibrosis
- (2022) Hema Mehta et al. Seminars in Immunopathology
- Structure and function of non-digestible carbohydrates in the gut microbiome
- (2022) R.A. Rastall et al. Beneficial Microbes
- A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
- (2022) Mikal Jacob Hole et al. HEPATOLOGY
- Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome
- (2021) Malte Christoph Rühlemann et al. NATURE GENETICS
- Associations of neopterin and kynurenine–tryptophan ratio with survival in primary sclerosing cholangitis
- (2021) Amandeep Kaur Dhillon et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Reduced immune-regulatory molecule expression on human colonic memory CD4 T cells in older adults
- (2021) Stephanie M. Dillon et al. Immunity & Ageing
- Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
- (2021) Lars Bossen et al. Clinical and Translational Gastroenterology
- Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
- (2021) Montserrat Puig et al. Frontiers in Immunology
- Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis
- (2021) Tobias Poch et al. JOURNAL OF HEPATOLOGY
- Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
- (2021) Maria Reich et al. JOURNAL OF HEPATOLOGY
- Intestinal CD8+ T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities
- (2021) R. R. C. E. Schreurs et al. Mucosal Immunology
- MAIT cells, guardians of skin and mucosa?
- (2021) Isabelle Nel et al. Mucosal Immunology
- Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
- (2021) Xiaolei Liu et al. Gastroenterology Research and Practice
- Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis
- (2021) Hongxia Zhang et al. Frontiers in Immunology
- Bile Microbiota in Liver Transplantation: Proof of Concept Using Gene Amplification in a Heterogeneous Clinical Scenario
- (2021) Francesco D'Amico et al. Frontiers in Surgery
- Nuclear receptors in liver fibrosis
- (2021) Philipp Königshofer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis
- (2021) Qiaoyan Liu et al. GUT
- Intestinal virome and therapeutic potential of bacteriophages in liver disease
- (2021) Cynthia Hsu et al. JOURNAL OF HEPATOLOGY
- DARK AND BRIGHT SIDE OF TARGETING THE FIBROBLAST GROWTH FACTOR RECEPTOR 4 IN THE LIVER
- (2021) Raffaella Maria Gadaleta et al. JOURNAL OF HEPATOLOGY
- A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells
- (2021) Christine L. Zimmer et al. Science Translational Medicine
- The gut vascular barrier: a new player in the gut–liver–brain axis
- (2021) Paola Brescia et al. TRENDS IN MOLECULAR MEDICINE
- Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
- (2021) Eleni Rebelos et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy
- (2021) Amber G. Bozward et al. Frontiers in Immunology
- Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis
- (2021) Fiorella D’Onofrio et al. Cells
- Autism-related dietary preferences mediate autism-gut microbiome associations
- (2021) Chloe X. Yap et al. CELL
- “Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
- (2021) Mark A. Febbraio et al. Cell Metabolism
- Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis
- (2021) Jonathon J. Graham et al. HEPATOLOGY
- Diet and gut microbiome in gastrointestinal disease
- (2021) Gina L. Trakman et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
- (2021) Ratika Sehgal et al. Nutrients
- Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
- (2021) Mateus Jorge Nardelli et al. Canadian Journal of Gastroenterology and Hepatology
- Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
- (2021) Rui Xue et al. Cells
- The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
- (2021) Kevin De Muynck et al. Cells
- Gut-derived systemic inflammation as a driver of depression in chronic liver disease
- (2021) Victoria T. Kronsten et al. JOURNAL OF HEPATOLOGY
- Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
- (2020) C.R.H. Hedin et al. Clinical Gastroenterology and Hepatology
- Monocytes as potential mediators of pathogen‐induced Th17 differentiation in patients with primary sclerosing cholangitis (PSC)
- (2020) Lilly Kristin Kunzmann et al. HEPATOLOGY
- Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes
- (2020) Matthew Peverelle et al. INFLAMMATORY BOWEL DISEASES
- A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways
- (2020) Mohammed Nabil Quraishi et al. Journal of Crohns & Colitis
- Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
- (2020) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis
- (2020) Timur Liwinski et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age
- (2020) Palak J. Trivedi et al. GASTROENTEROLOGY
- Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
- (2020) Masanori Furukawa et al. HEPATOLOGY RESEARCH
- The liver as an immunological barrier redefined by single‐cell analysis
- (2020) Zania Stamataki et al. IMMUNOLOGY
- Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
- (2020) Mette Vesterhus et al. JOURNAL OF GASTROENTEROLOGY
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- Paneth cells promote angiogenesis and regulate portal hypertension in response to microbial signals
- (2020) Mohsin Hassan et al. JOURNAL OF HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease
- (2020) Zhangran Chen et al. Frontiers in Microbiology
- Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis
- (2020) Trevor J. Laborda et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis
- (2020) Ahmad Hassan Ali et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals
- (2020) Jiamin Lou et al. Frontiers in Cellular and Infection Microbiology
- Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
- (2020) Yongyan Chen et al. Cellular & Molecular Immunology
- Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
- (2020) Laura Valestrand et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Oral vancomycin, ursodeoxycholic acid or no therapy for pediatric primary sclerosing cholangitis: a matched analysis
- (2020) Mark R. Deneau HEPATOLOGY
- Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis
- (2020) Y. Lapidot et al. Hepatology International
- Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis
- (2020) Emma L Culver et al. LIVER INTERNATIONAL
- Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma
- (2020) Elsemieke de Vries et al. LIVER INTERNATIONAL
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- Understanding the impact of antibiotic perturbation on the human microbiome
- (2020) D. J. Schwartz et al. Genome Medicine
- Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells
- (2020) Hongxia Zhang et al. Frontiers in Immunology
- Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis
- (2020) Martin Kummen et al. GASTROENTEROLOGY
- Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
- (2020) Chathur Acharya et al. GASTROENTEROLOGY
- Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases
- (2020) Iliyan D. Iliev et al. GASTROENTEROLOGY
- Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
- (2019) Samuel P. Costello et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
- (2019) Nobuhiro Nakamoto et al. Nature Microbiology
- Tissue-resident Eomes+ NK cells are the major innate lymphoid cell population in human infant intestine
- (2019) Adrian F. Sagebiel et al. Nature Communications
- Cholangiocyte pathobiology
- (2019) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis
- (2019) Alexander Dao et al. INFLAMMATORY BOWEL DISEASES
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- Hepatic Manifestations of Cystic Fibrosis
- (2019) Sasan Sakiani et al. Clinics in Liver Disease
- Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
- (2019) Weihua Chen et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis
- (2019) Jessica R. Allegretti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation
- (2019) Iris C. Steenstraten et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
- (2019) Kate D. Lynch et al. Clinical Gastroenterology and Hepatology
- Leaky gut: mechanisms, measurement and clinical implications in humans
- (2019) Michael Camilleri GUT
- Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis
- (2019) Sara Lemoinne et al. GUT
- Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
- (2019) Benedicte Caron et al. Journal of Crohns & Colitis
- PS-024-Early TIPS with covered stent versus standard treatment for acute variceal bleeding among patients with advanced cirrhosis: A randomised controlled trial
- (2019) Yong Lv et al. JOURNAL OF HEPATOLOGY
- Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
- (2019) Nicola Principi et al. Frontiers in Pharmacology
- Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
- (2019) Almut Heinken et al. Microbiome
- Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
- (2019) Malte Rühlemann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals
- (2019) Helena Mendes-Soares et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Alterations of gut microbiome in autoimmune hepatitis
- (2019) Yiran Wei et al. GUT
- Alterations of the bile microbiome in primary sclerosing cholangitis
- (2019) Timur Liwinski et al. GUT
- Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
- (2019) Clara Depommier et al. NATURE MEDICINE
- Microbial genes and pathways in inflammatory bowel disease
- (2019) Melanie Schirmer et al. NATURE REVIEWS MICROBIOLOGY
- The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile
- (2019) Natalia Molinero et al. Microbiome
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
- (2019) Sara Vieira-Silva et al. Nature Microbiology
- Systematic Review and Meta-analysis: Short-Chain Fatty Acid Characterization in Patients With Inflammatory Bowel Disease
- (2019) Xiaojun Zhuang et al. INFLAMMATORY BOWEL DISEASES
- Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease
- (2019) Yiwen Zhang et al. BMC GENOMICS
- Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
- (2019) Malte Christoph Rühlemann et al. GUT
- Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience
- (2019) Ming-Hsi Wang et al. INFLAMMATORY BOWEL DISEASES
- The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease
- (2019) Huikuan Chu et al. JOURNAL OF HEPATOLOGY
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- (2019) Yi Duan et al. NATURE
- Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review
- (2019) Rapat Pittayanon et al. GASTROENTEROLOGY
- Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
- (2018) B. Christensen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease
- (2018) C. S. Tse et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis
- (2018) P. J. Trivedi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
- (2018) Allison Agus et al. Cell Host & Microbe
- Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon
- (2018) Noa Krugliak Cleveland et al. Clinical Gastroenterology and Hepatology
- High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease
- (2018) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series
- (2018) Romain Altwegg et al. DIGESTIVE AND LIVER DISEASE
- Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor–Positive Cells and Pathogenesis of Cholestatic Liver Disease
- (2018) Dana Tedesco et al. GASTROENTEROLOGY
- Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
- (2018) Cyriel Y. Ponsioen et al. HEPATOLOGY
- Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
- (2018) Preeti Pathak et al. HEPATOLOGY
- Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis
- (2018) Mohamad A Mouchli et al. INFLAMMATORY BOWEL DISEASES
- Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
- (2018) Martin Kummen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Human intraepithelial lymphocytes
- (2018) Toufic Mayassi et al. Mucosal Immunology
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease
- (2018) Kazumichi Abe et al. PLoS One
- Do Long-Lived Plasma Cells Maintain a Healthy Microbiota in the Gut?
- (2018) Frode L. Jahnsen et al. TRENDS IN IMMUNOLOGY
- Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
- (2018) Tamas Tornai et al. Scientific Reports
- Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
- (2018) Kentaro Iwasawa et al. Scientific Reports
- 5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
- (2018) Jun Xu et al. Frontiers in Microbiology
- Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome
- (2018) Jane M. Natividad et al. Cell Metabolism
- The Microbiome in Cirrhosis and Its Complications
- (2018) Chathur Acharya et al. Clinical Gastroenterology and Hepatology
- Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
- (2018) Guillaume Pineton de Chambrun et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells
- (2018) Erik von Seth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis–ulcerative colitis
- (2018) Li-Zsa Tan et al. GUT
- Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
- (2018) Amandeep K Dhillon et al. LIVER INTERNATIONAL
- Natural killer T cells mediate inflammation in the bile ducts
- (2018) N. L. Berntsen et al. Mucosal Immunology
- Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
- (2018) Samer Al-Dury et al. Scientific Reports
- Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype
- (2018) Mandy Sowa et al. Frontiers in Immunology
- Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
- (2018) Ara Koh et al. CELL
- Statin Use is Associated with Improved Outcomes of Patients With Primary Sclerosing Cholangitis
- (2018) Knut Stokkeland et al. Clinical Gastroenterology and Hepatology
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid
- (2018) Elliot S. Friedman et al. GASTROENTEROLOGY
- Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis
- (2018) Pamela Tietz-Bogert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Origin, Differentiation, and Function of Intestinal Macrophages
- (2018) Calum C. Bain et al. Frontiers in Immunology
- Gut microbiome structure and metabolic activity in inflammatory bowel disease
- (2018) Eric A. Franzosa et al. Nature Microbiology
- Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases
- (2017) Susanna Nikolaus et al. GASTROENTEROLOGY
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
- (2017) Tobias J. Weismüller et al. GASTROENTEROLOGY
- Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy
- (2017) Ruqi Tang et al. GUT
- Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner
- (2017) Palak J Trivedi et al. GUT
- Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study
- (2017) Elisabeth M. G. de Vries et al. HEPATOLOGY
- Regionalized Development and Maintenance of the Intestinal Adaptive Immune Landscape
- (2017) William W. Agace et al. IMMUNITY
- Dissecting human ILC heterogeneity: more than just three subsets
- (2017) Yannick Simoni et al. IMMUNOLOGY
- Tissue adaptation: Implications for gut immunity and tolerance
- (2017) Ana M.C. Faria et al. JOURNAL OF EXPERIMENTAL MEDICINE
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
- (2017) Eva Kristine Klemsdal Henriksen et al. JOURNAL OF HEPATOLOGY
- The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
- (2017) Elisabeth Schrumpf et al. JOURNAL OF HEPATOLOGY
- Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
- (2017) Vinod S Hegade et al. LANCET
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
- (2017) Sudarshan Paramsothy et al. LANCET
- Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011
- (2017) Jakob Ørskov Sørensen et al. LIVER INTERNATIONAL
- Genetics of primary sclerosing cholangitis and pathophysiological implications
- (2017) Xiaojun Jiang et al. Nature Reviews Gastroenterology & Hepatology
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
- (2017) Lukas Bajer et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties
- (2017) Aline Van Acker et al. Cell Reports
- The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease
- (2017) J Torres et al. United European Gastroenterology Journal
- Innate Lymphoid Cells in Intestinal Inflammation
- (2017) Alessandra Geremia et al. Frontiers in Immunology
- Differential Location and Distribution of Hepatic Immune Cells
- (2017) Maria Freitas-Lopes et al. Cells
- Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
- (2017) Pedro Pereira et al. PLoS One
- The features of mucosa-associated microbiota in primary sclerosing cholangitis
- (2016) J. Torres et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis
- (2016) Long-Xian Lv et al. ENVIRONMENTAL MICROBIOLOGY
- Primary sclerosing cholangitis associated with inflammatory bowel disease
- (2016) Irene Franceschet et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
- (2016) Aida Kapic Lunder et al. GASTROENTEROLOGY
- Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
- (2016) Floris Imhann et al. GUT
- The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
- (2016) Mohammed Nabil Quraishi et al. GUT
- Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis
- (2016) Kentaro Iwasawa et al. GUT
- Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
- (2016) João Sabino et al. GUT
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
- (2016) Sebastian Torben Jendrek et al. GUT
- Fungal microbiota dysbiosis in IBD
- (2016) Harry Sokol et al. GUT
- Low-grade endotoxemia and platelet activation in cirrhosis
- (2016) Valeria Raparelli et al. HEPATOLOGY
- Short- and long-term effects of oral vancomycin on the human intestinal microbiota
- (2016) Sandrine Isaac et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity
- (2016) Palak J. Trivedi et al. JOURNAL OF AUTOIMMUNITY
- Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
- (2016) Maria K. Magnusson et al. Journal of Crohns & Colitis
- Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation
- (2016) Kilian Friedrich et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A triple blinded, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of oral vancomycin in primary sclerosing cholangitis: a pilot study
- (2016) Journal of Gastrointestinal and Liver Diseases
- Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
- (2016) Takeji Umemura et al. LIVER INTERNATIONAL
- Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
- (2016) Johannes R. Hov et al. LIVER INTERNATIONAL
- Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
- (2016) S F Jørgensen et al. Mucosal Immunology
- Human gut microbes impact host serum metabolome and insulin sensitivity
- (2016) Helle Krogh Pedersen et al. NATURE
- Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
- (2016) Sun-Gou Ji et al. NATURE GENETICS
- Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota
- (2016) Jun Wang et al. NATURE GENETICS
- CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
- (2016) Bruno Lamas et al. NATURE MEDICINE
- Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function
- (2016) Martin Kummen et al. United European Gastroenterology Journal
- Gut microbiota diversity predicts immune status in HIV-1 infection
- (2015) Piotr Nowak et al. AIDS
- Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation
- (2015) Kaija-Leena Kolho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Personalized Nutrition by Prediction of Glycemic Responses
- (2015) David Zeevi et al. CELL
- Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
- (2015) Zeneng Wang et al. CELL
- The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
- (2015) Aleksandar D. Kostic et al. Cell Host & Microbe
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease
- (2015) Frederike Schmitz et al. GUT
- Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
- (2015) James H. Tabibian et al. HEPATOLOGY
- The biliary epithelium presents antigens to and activates natural killer T cells
- (2015) Elisabeth Schrumpf et al. HEPATOLOGY
- Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
- (2015) Cyriel Y. Ponsioen et al. HEPATOLOGY
- Interleukin-12 and -23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
- (2015) Jochem H. Bernink et al. IMMUNITY
- Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
- (2015) D. Kevans et al. Journal of Crohns & Colitis
- Methods to determine intestinal permeability and bacterial translocation during liver disease
- (2015) Lirui Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A gut-vascular barrier controls the systemic dissemination of bacteria
- (2015) Ilaria Spadoni et al. SCIENCE
- Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes
- (2015) Stefanía Magnúsdóttir et al. Frontiers in Genetics
- Dietary effects on human gut microbiome diversity
- (2014) Zhenjiang Xu et al. BRITISH JOURNAL OF NUTRITION
- Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease
- (2014) Noah W. Palm et al. CELL
- The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
- (2014) Dirk Gevers et al. Cell Host & Microbe
- Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis
- (2014) Craig Lammert et al. Clinical Gastroenterology and Hepatology
- The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
- (2014) Noortje G. Rossen et al. Journal of Crohns & Colitis
- Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis
- (2014) Lauren N Bell et al. LIVER INTERNATIONAL
- Protective mucosal immunity mediated by epithelial CD1d and IL-10
- (2014) Torsten Olszak et al. NATURE
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
- (2013) J. H. Tabibian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach
- (2013) Xiao Wei et al. BMC GASTROENTEROLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis
- (2013) Ina Marie Andersen et al. Clinical Gastroenterology and Hepatology
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
- (2013) Janosch Katt et al. HEPATOLOGY
- Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
- (2013) Atsushi Tanaka et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
- (2013) Genta Kakiyama et al. JOURNAL OF HEPATOLOGY
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
- (2013) Anne Vrieze et al. JOURNAL OF HEPATOLOGY
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- (2013) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- Dietary vitamin B6 intake modulates colonic inflammation in the IL10−/− model of inflammatory bowel disease
- (2013) Jacob Selhub et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
- (2013) Jimmy Z Liu et al. NATURE GENETICS
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
- (2013) V. K. Ridaura et al. SCIENCE
- Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation Is Associated With Reduced Need for Colectomy in Patients With Ulcerative Colitis
- (2012) Udayakumar Navaneethan et al. Clinical Gastroenterology and Hepatology
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
- (2012) David N. Abarbanel et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
- (2012) Trine Folseraas et al. JOURNAL OF HEPATOLOGY
- Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
- (2012) Pablo Bellot et al. LIVER INTERNATIONAL
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 −/− mice
- (2012) Suzanne Devkota et al. NATURE
- Bile Acids Regulate Cardiovascular Function
- (2011) Sandeep Khurana et al. CTS-Clinical and Translational Science
- Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study
- (2011) Jocelyn Trottier et al. DIGESTIVE AND LIVER DISEASE
- Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB—Mediated Inflammatory Response in Mice
- (2011) Romina Fiorotto et al. GASTROENTEROLOGY
- Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
- (2011) L. Marelli et al. GUT
- Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients
- (2011) Kristin Kaasen Jrgensen et al. INFLAMMATORY BOWEL DISEASES
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis
- (2011) Jingmin Zhao et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Update on primary sclerosing cholangitis
- (2010) Tom H. Karlsen et al. DIGESTIVE AND LIVER DISEASE
- Immune reactivity to -tubulin isotype 5 and vesicular integral-membrane protein 36 in patients with autoimmune gastrointestinal disorders
- (2010) K. Op De Beeck et al. GUT
- Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden
- (2010) Björn Lindkvist et al. HEPATOLOGY
- Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage
- (2009) Rita Cariello et al. DIGESTIVE AND LIVER DISEASE
- Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- (2009) Tom H. Karlsen et al. GASTROENTEROLOGY
- p-ANCAs in autoimmune liver disorders recognise human -tubulin isotype 5 and cross-react with microbial protein FtsZ
- (2009) B. Terjung et al. GUT
- Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
- (2009) Gerda Rudolph et al. JOURNAL OF HEPATOLOGY
- Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic
- (2009) Yinka K Davies et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- NKT cells in mucosal immunity
- (2009) S Middendorp et al. Mucosal Immunology
- Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
- (2009) Koji Hase et al. NATURE
- What are the consequences of the disappearing human microbiota?
- (2009) Martin J. Blaser et al. NATURE REVIEWS MICROBIOLOGY
- Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
- (2008) Marina G Silveira et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
- (2008) Frank P. Vleggaar et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Characterization of a Streptococcus sp.-Veillonella sp. Community Micromanipulated from Dental Plaque
- (2008) N. I. Chalmers et al. JOURNAL OF BACTERIOLOGY
- A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis
- (2008) Daan W. Hommes et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis
- (2008) Liesbet Henckaerts et al. JOURNAL OF HEPATOLOGY
- Autoantibodies in primary sclerosing cholangitis
- (2008) Johannes Roksund Hov et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started